Lv1
80 积分 2025-04-06 加入
P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling
6个月前
已关闭
Baricitinib: The Second FDA-Approved JAK Inhibitor for the Treatment of Rheumatoid Arthritis
9个月前
已完结
Reposicionamento do fármaco baricitinibe para o tratamento da COVID-19
1年前
已关闭
皖公网安备34019202002308
